Fetal rabbits were treated with corticosteroids by maternal administration for 48 h before delivery at 27 d gestational age. The treated and control rabbits were placed on ventilator-plethysmographs so that ventilation could be adjusted by regulation of tidal volumes to 10-13 ml/kg body wt. I1IIalbumin was mixed with fetal lung fluid at birth, alternate rabbits from each litter were treated with Surfactant-TA, and I131Ialbumin was injected intravascularly. The movement of the labeled albumins into and out of the alveolar wash and lung tissue was measured after 30 min of ventilation. Corticosteroid treatment (total dose, 0.2 mg/ kg betamethasone) significantly decreased the protein leak across the endothelium (P < 0.001) but increased the protein leak across the epithelium (P < 0.001). Surfactant treatment decreased both the endothelial and epithelial leaks, and the combination of surfactant and corticosteroid treatments decreased endothelial leaks to 29% of control values and increased compliance more than either treatment alone. The 48-h corticosteroid treatment did not increase alveolar surfactant pool sizes. Corticosteroids significantly changed lung protein leaks independently of surfactant, and improved the response of the preterm lung to surfactant treatments.
Introduction
The maternal administration of corticosteroids given at least 48 h before delivery decreases the incidence and severity of respiratory distress syndrome (RDS)' in preterm infants (1, 2) . A major effect ofcorticosteroids on the developing lung is thought to result from stimulation of surfactant synthesis (3, 4) , because a deficiency of surfactant is central to the pathophysiology of RDS (5) . Numerous experiments in animals document that maternally administered corticosteroids will increase choline incorporation rates into fetal lungs and lung explants (6) . Corticosteroids stimulate palmitic acid synthesis in the fetal lung and cause glycogen to disappear from type II cells, indicating effects on surfactant precursor pools (7, 8) . Corticosteroids also cause a growth arrest of the fetal lung and stimulate alveolarization (9, 10) . Corticosteroids change the mechanical properties of the fetal lung as assessed by static pressure-volume curves, an effect that may be independent of changes in surfactant pools (1 1). While antenatal dexamethasone reduces the incidence and severity of RDS in preterm monkeys, the effects are not confined to changes in surfactant pools (12, 13) .
Pulmonary edema, protein leaks, and small airway epithelial damage are characteristic of the lungs of ventilated infants and animals with RDS (14, 15) . The soluble proteins that enter the airways can interact with the already inadequate amounts of surfactant and further compromise surfactant function (16) . Corticosteroids were shown to decrease the permeability of the postnatal rat lung to low molecular weight drugs and to accelerate renal functional maturation in fetal lambs (17, 18) . Independent of their effect on lung maturation, corticosteroids have other effects on preterm infants such as decreasing the incidence of necrotizing enterocolitis, ductus arteriosus, and serum electrolyte abnormalities (19, 20) . These and other responses in preterm animals and infants likely are mediated at least in part by effects on the endothelium and/or epithelium. Therefore, we asked if corticosteroids could change the protein leaks characteristic of the preterm ventilated lung. Because surfactant treatment ofRDS appears to be helpful, there was a secondary question of what the effect of a surfactant treatment on the lung previously treated with corticosteroids would be.
Methods
Corticosteroid treatments. 11 pregnant New Zealand White rabbits received intramuscular injections of 0.1 mg betamethasone per kg (Celestone Soluspan, Schering Corp., Kenilworth, NJ) on gestational days 25 and 26, 48 and 24 h before delivery ofthe fetuses on day 27 ofgestation. Eight other does received vehicle injections only. A second group ofeight pregnant does received 0.1 mg betamethasone per kg by intramuscular injection and 0.1 mg dexamethasone per kg by intravascular injection 4 h before delivery of the fetuses. Eight pregnant does received vehicle injections at the same time before delivery.
Delivery offetuses. The does received intravenous pentobarbital to achieve light anesthesia and oxygen by face mask. The abdominal wall was anesthetized with 1% lidocaine, and the uterus was exposed. Fetal rabbits were sequentially removed and weighed, and a tube made from an 18-gauge needle was tied into the trachea of each rabbit via a neck incision. Alternate rabbits received 120 ,l of 0.9% saline containing 1 MCi ['25I]albumin (-2 ,ug protein) or 120 Ml saline containing the labeled albumin plus 2.25 mg Surfactant-TA. The surfactant was prepared from beef lung and kindly provided by the Tokyo Tanabe Co., Tokyo, Japan. This surfactant has been extensively characterized and was effective in clinical trials for the treatment of RDS (21) . The tracheal tube of each rabbit then was connected to a 0.5 I anesthesia bag delivering 100% oxygen, and the rabbit was ventilated with initial peak pressures of 35 cmH2O and inspiratory times of about 0.5 s for about five breaths until satisfactory chest motion occurred. The rabbit then was transferred to the ventilator. The rabbit received a 0.2-ml intravascular injection of 1 MCi ["3'I]albumin in 0.9% NaCl via the external jugular vein. The time between delivery and placement on the ventilator averaged 2 min, and about 1 min more was required to complete the intravascular injection.
Ventilation of rabbits. The rabbits were ventilated in a series of 10 plexiglas boxes that were maintained at 370C with a circulating water bath. The ventilatory circuit was modified from that described by Lachmann et al. (22) to be a rebreathing circuit that permitted the peak pressures to be independently varied for each rabbit (Fig. 1.) . Soda lime was placed in a cartridge to absorb Co2 just proximal to the entrance of the endotracheal tube into the ventilator circuit. A pressure-limited infant ventilator (Sechrist Industries, Inc., Anaheim, CA) was used to drive the 10 ventilator circuits. Ventilator settings were a rate of 40 breaths/min with a 1:1 inspiratory-to-expiratory time ratio, 100% oxygen, and no positive end expiratory pressure. Tidal volumes delivered to each rabbit were measured with a pneumotachygraph connected to the plexiglas box. The pressure changes across the pneumotachygraph were measured with a differential pressure transducer (Validyne Engineering Corp., Northridge, CA) and electronically integrated to volumes. Knowing the weight of each rabbit, the peak inspiratory pressure delivered to each rabbit was adjusted such that the tidal volume would be between 10 and 13 ml/kg. Volume measurements and any necessary pressure adjustments were made at least every 5 min for each rabbit. Compliance was calculated by dividing tidal volume per kilogram body weight by the peak inspiratory pressure. 30 min after the initiation of ventilation, each rabbit was disconnected from the ventilator and killed with an intracerebral injection of lidocaine that stopped the heart immediately. The chest was rapidly opened and blood was drawn into a heparinized syringe from the heart. Blood Pco2 and pH values were measured, and blood was saved to measure radiolabeled albumin and hemoglobin. The sex of each rabbit was determined by examination of the gonads (23 (15) . The hemoglobin associated with the lung homogenates was assumed to be from intravascular blood, and the blood-associated radioactivity was subtracted from that measured for each lung (I15). Labeled albumin recoveries were expressed as percent of injected dose.
Aliquots of the alveolar washes and lung homogenates were extracted with chloroform/methanol (24) . The pressure to about 14 cm H20. There were no differences in any of the mean values in Table I when the data were analyzed by the sex of the rabbits. Protein leaksfrom vascular space to lungs (48-h treatment). The intravascularly injected [3'I] albumin could be used to indicate different protein leaks into the lungs ofthe corticosteroid and control animals only if comparable amounts of the label remained in the intravascular space during the 30-min measurement. In control experiments we found comparable blood volumes and percent recoveries of the intravascular albumin in the organs and carcass at sacrifice in corticosteroid and control rabbits. The total recoveries were 41.8 and 37.3%, respectively, for control and corticosteroid-treated rabbits, indicating very similar amounts of the injected isotope remained in the intravascular space and thus had a chance to leak into the lungs. Large leaks present in control lungs were decreased significantly by both corticosteroids and surfactant (Table II) . The leak of [13'I] albumin from the vascular space into the lung tissue and alveolar wash decreased by 30% with corticosteroid treatment, whereas surfactant alone decreased the leak to 50% ofcontrol values. The combined treatments decreased the leak into the alveoli to 13% of control values and into the total lung (alveolar wash plus lung tissue) to 29% of the control values. The mean pressures required to ventilate the control and corticosteroid groups were similar but the protein leak was decreased; therefore, corticosteroids decreased the vascular to lung protein leak independently of a pressure effect. This conclusion was supported by the correlations of protein leak from the vascular space to the lungs with the peak inspiratory pressures needed to ventilate the rabbits (Fig. 3) (Fig. 4) . The slopes ofthe curves for alveolar wash and total lung for the corticosteroid-treated rabbits were not different from the slopes for the control rabbits; however, the curves were different by an analysis of covariance. Overall corticosteroid treatment increased the loss of protein from the lungs. Surfactant treatments decreased the protein leak in proportion to the effect of surfactant on ventilatory pressures. The combination ofsurfactant and corticosteroid treatments did not change the increased leak caused by the corticosteroids. The differences in leak following corticosteroid treatment could be demonstrated using either the data for rabbits not treated with surfactant or the pooled data that included the surfactant-treated rabbits. No sex-dependent differences in any of the protein leak measurements were noted. Results after 4 h ofcorticosteroids. The rabbits delivered from the does treated with corticosteroids 4 h before delivery had significantly lower pH values at 30 min ofage than did the control rabbits (Table III) . Tidal volumes and Pco2 values were comparable, indicating comparable ventilation. Therefore, corticosteroid treatments shortly before delivery caused a significant metabolic acidosis. Corticosteroid treatment did not alter the peak pressures required to achieve the desired tidal volumes, whereas surfactant significantly and comparably decreased the pressures in both groups. There were no effects of corticosteroids on body weight or saturated phosphatidylcholine pool sizes. The protein leak measurements were not changed by the corticosteroid treatment (Table IV) . Whereas surfactant mediated effects similar to those measured in the rabbits treated with corticosteroids for 48 h were seen, the short-term corticosteroid treatment did not augment the surfactant effects. The protein leak variables correlated with ventilatory pressures, but corticosteroids did not change the relationships (Fig. 5 ).
Discussion
The protein leak abnormalities characteristic of the pretermventilated lung were measured previously in the lamb (15) .
Whereas we recently demonstrated that surfactant treatments will decrease protein leak in the ventilated rabbit, these studies were compromised by our inability to regulate ventilation for each rabbit (27) . The by Pco2 values in the different groups of rabbits. Because blood was taken for pH and Pco2 measurements after sacrifice and the blood was from the right and/or left ventricles, P02 values were not reported. However, the surfactant-treated rabbits were more pink, indicating improved oxygenation relative to the groups not treated with surfactant. The ventilated preterm rabbit model permits the investigator to study a large number of animals. However, results can be easily biased if sufficient litters are not studied, because the variation in responses of rabbits between litters exceeded the variation within each litter. We studied rabbits from at least eight litters for each treatment group.
The effects ofcorticosteroids on lung maturation in the rabbit have been studied following direct fetal injection or maternal administration (6) . Direct fetal administration ofcorticosteroids caused dramatic morphologic maturation of type II cells (29, 30) , increased lung stability (3) , and caused a 4.6-fold increase in alveolar phosphatidylcholine (31) . However, maternal ad- ministration of 0.4 mg/kg betamethasone caused less than a twofold increase in alveolar total and saturated phosphatidylcholine, and higher doses resulted in fetal death (23, 31) . The total dose of0.2 mg/kg betamethasone chosen for this study was the lowest dose reported to effect lung maturation in the rabbit following maternal administration (32) . This dose was less than the -0.2 mg/kg dose of dexamethasone given every 12 h for 4 doses to the human to prevent RDS (2) . Of course fetal growth rates differ significantly in the human and rabbit so that the drug doses are not strictly comparable. Despite the low dose of corticosteroids, fetal death, abortion, and significant growth retardation occurred. In our study, no increase in surfactant pool size was detected, consistent with the lack of effect of corticosteroids on the peak pressures needed to ventilate the rabbits. The lack of effect on endogenous surfactant pools may in part result from the low dose ofcorticosteroids used in these protocols. Nevertheless, corticosteroids clearly affected the lungs because surfactant treatment of the corticosteroid-treated rabbits resulted in a significant decrease in peak inspiratory pressures and an increase in compliance relative to the surfactant-treated control group. This result indicated that lung structure was likely modified to permit an enhanced surfactant effect. Mitzner et al. (9) documented structural changes in the preterm monkey lung following 13 d of corticosteroid treatment that suggested a stimulation of alveolarization. Bunton and Plopper (10) found definite early alveolarization in preterm monkeys following highdose corticosteroid treatments, and Kotas and Avery (3) found a twofold increase in gas volume in 27 d gestational age fetal rabbits following direct fetal injection with corticosteroids. While these studies involved prolonged and/or high-dose steroid treatments, we found a 50% increase in lung volume per gram dry lung weight in rabbits treated with the 0.2 mg/kg corticosteroid dose (33) . Our studies in rabbits indicated that corticosteroids "primed" the lung to respond favorably to large exogenously administered doses of surfactant. By analogy, infants with RDS despite having received corticosteroids may have excellent responses to surfactant treatments. The effect of corticosteroids on lung protein leaks can be interpreted by considering the lung as three compartments: the vascular space, the interstitium here represented by lung tissue, and the airways and alveoli. Protein leaks were large and bidirectional. In control animals not treated with surfactant, -9% (35) . Following term birth, an adaptive process occurs that results in the rapid clearance offluid and small molecular weight solutes from the airways and alveoli. Based on measurements made with solutes of different molecular weights and interpreted in terms of a pore size theory, the pores in the pulmonary epithelium increase transiently after birth from 6 gm to 40 ,m (35) . Possibly this mechanism allowing the newborn to clear fetal lung fluid was "induced" in the preterm lung by corticosteroids.
We also studied rabbits after 4 h ofexposure to corticosteroids to document that the effects of corticosteroids on protein leaks were related to the maturational effects of corticosteroids and not a primarily pharmacologic effect. The does received the same dose of betamethasone by intramuscular injection as was used for the 48-h exposure protocol as well as 0.1 mg/kg dexamethasone by intravascular injection to assure short-term fetal exposure. Both these synthetic corticosteroids have similar poten- Taken together the decreased endothelial leak and the increased epithelial leak following 48 h of fetal exposure to corticosteroids could influence the evolution of pulmonary edema in the preterm lung unpredictably. The decreased endothelial leak would seem to be highly desirable because interstitial edema would be minimized. On the other hand, an increased epithelial leak, if not a transient adaptive response to birth (35) , would allow the interstitial proteins to enter the airways and alveoli. These proteins contribute to the formation ofhyaline membranes (14) and may inhibit the surface tension-lowering properties of the surfactant (16) .
The protein leaks characteristic of the preterm ventilated lung decrease as gestational age increases (15) (38) .
These studies demonstrate that corticosteroids influence the protein leak by changing the epithelial and endothelial components of the leak in opposite directions. The protein leak in the preterm-ventilated lung can be manipulated by physical and pharmacologic means. These results imply that strategies can be developed for the care of the preterm infant that may favorably influence pulmonary edema and surfactant function. The most striking result was the dramatic effect of combined corticosteroid and surfactant treatments on lung function and protein leak. The surfactant treatment decreased the endothelial leak of protein as measured in the lung in control animals to 50% of control values, whereas this leak decreased to 29% of control values with the two treatments. In contrast surfactant treatment did not change epithelial leaks of the steroid-treated animals, despite the increased lung volumes resulting from surfactant treatment (21) . Also, the epithelial leak of the surfactantplus-corticosteroid-treated animals was not decreased relative to the surfactant treated group despite lower ventilatory pressures. These studies indicate that corticosteroid treatments of the preterm rabbit lung significantly change protein leaks with little demonstrable effect on the surfactant system. The responses of the corticosteroid-treated lungs to exogenously administered surfactant suggest functional improvements related to structural changes in the lungs.
